Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,050 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association between change in self-efficacy and reduction in disability among patients with chronic pain.
Karasawa Y, Yamada K, Iseki M, Yamaguchi M, Murakami Y, Tamagawa T, Kadowaki F, Hamaoka S, Ishii T, Kawai A, Shinohara H, Yamaguchi K, Inada E. Karasawa Y, et al. Among authors: yamaguchi m, yamaguchi k. PLoS One. 2019 Apr 16;14(4):e0215404. doi: 10.1371/journal.pone.0215404. eCollection 2019. PLoS One. 2019. PMID: 30990842 Free PMC article. Clinical Trial.
In Vitro Analyses of Spinach-Derived Opioid Peptides, Rubiscolins: Receptor Selectivity and Intracellular Activities through G Protein- and β-Arrestin-Mediated Pathways.
Karasawa Y, Miyano K, Fujii H, Mizuguchi T, Kuroda Y, Nonaka M, Komatsu A, Ohshima K, Yamaguchi M, Yamaguchi K, Iseki M, Uezono Y, Hayashida M. Karasawa Y, et al. Among authors: yamaguchi m, yamaguchi k. Molecules. 2021 Oct 8;26(19):6079. doi: 10.3390/molecules26196079. Molecules. 2021. PMID: 34641621 Free PMC article.
Evaluation of the Intracellular Signaling Activities of κ-Opioid Receptor Agonists, Nalfurafine Analogs; Focusing on the Selectivity of G-Protein- and β-Arrestin-Mediated Pathways.
Yamaguchi M, Miyano K, Hirayama S, Karasawa Y, Ohshima K, Uezono E, Komatsu A, Nonaka M, Fujii H, Yamaguchi K, Iseki M, Hayashida M, Uezono Y. Yamaguchi M, et al. Among authors: yamaguchi k. Molecules. 2022 Oct 19;27(20):7065. doi: 10.3390/molecules27207065. Molecules. 2022. PMID: 36296658 Free PMC article.
Therapeutic Potential of Orally Administered Rubiscolin-6.
Karasawa Y, Miyano K, Yamaguchi M, Nonaka M, Yamaguchi K, Iseki M, Kawagoe I, Uezono Y. Karasawa Y, et al. Among authors: yamaguchi m, yamaguchi k. Int J Mol Sci. 2023 Jun 9;24(12):9959. doi: 10.3390/ijms24129959. Int J Mol Sci. 2023. PMID: 37373107 Free PMC article. Review.
6,050 results